Skip to content
← Holders

Euclidean Capital LLC

What Euclidean Capital LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1825034 · Filed Nov 16, 2026

Positions
10
Reported value
$323.6M
Opened
1
Closed
2
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$238M
    11 positions
  2. Dec 31, 2025$369.5M
    12 positions
  3. Mar 31, 2026$392.3M
    10 positions
  4. Jun 30, 2026$439.8M
    11 positions
  5. Sep 30, 2026$323.6M
    10 positions
SecuritySharesChangeValueOf portfolio
VANGUARD INTL EQUITY INDEX FALLWRLD EX US
3.2M±0%$269.1M83.2%
ISHARES TRMSCI INDIA ETF
369.6K±0%$17.3M5.3%
ORICOric Pharmaceuticals, Inc.
989.4K±0%$13.3M4.1%
TMSTeamshares Inc
1.1M±0%$8M2.5%
FHTXFoghorn Therapeutics Inc.
1.6M±0%$5.6M1.7%
PMVPPMV Pharmaceuticals, Inc.
2.6M±0%$4.4M1.4%
SRZNSurrozen, Inc.
87.7K±0%$2.8M0.9%
ALECAlector, Inc.
1.3M±0%$2.4M0.7%
TNYATenaya Therapeutics, Inc.
1M±0%$613.1K0.2%
MRLNMerlin, Inc.
47.6KNew$89.5K0.1%